Are you Scott Sanders, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileScott Sanders, M.D. is a healthcare provider in New City, NY specializing in dermatopathology. Scott trained at Harvard Medical School, graduating in 1998. Medicare claims data shows Scott provided 20,787 services to 7,162 patients. The services billed most often include destruction of precancer skin growth, 2-14 growths, established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more, and injection, tildrakizumab, 1 mg. This provider record is associated with NPI 1780670927.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
301 N MAIN ST SUITE 3
New City, NY 10956
Within Pathology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Autoimmune & Joints
Autopsy & Forensic
Blood & Metabolism
Blood Disorders
Cancer
Cervical & Gynecologic
Digestive
Digestive System
Endocrine
Genetics
Hormones
Immune System
Infections
Kidney
Liver
Metabolic & Routine Lab
Pregnancy & Fertility
Skin Cancer
Women's Health
Cytology & Screening
Autopsy & Forensic
Blood Tests
Cytology
Genetic & Molecular Tests
Genetics
Immune & Allergy Tests
Infection Testing
Infection Tests
Lab & Blood Tests
Pathology Review
Pregnancy & Fertility
Routine Lab Tests
Tissue Biopsy
20,787 services · 7,162 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | Procedure | 17003 |
4,446 | More than most peers in Dermatopathology |
| Destruction of precancer skin growth, 1 growth | Procedure | 17000 |
1,190 | More than most peers in Dermatopathology |
| Destruction of skin growth, 1-14 growths | Procedure | 17110 |
1,168 | More than most peers in Dermatopathology |
| Biopsy of related skin growth, first growth | Procedure | 11102 |
861 | More than most peers in Dermatopathology |
| Biopsy of related skin growth, each additional growth | Procedure | 11103 |
324 | More than most peers in Dermatopathology |
| Destruction of precancer skin growth, 15 or more growths | Procedure | 17004 |
251 | More than most peers in Dermatopathology |
| Acne surgery | Procedure | 10040 |
178 | Too few peers to compare |
| Destruction of skin growth, 15 or more growths | Procedure | 17111 |
172 | More than most peers in Dermatopathology |
| Punch biopsy, first skin growth | Procedure | 11104 |
85 | More than most peers in Dermatopathology |
| Injection into skin growth, 1-7 growths | Procedure | 11900 |
84 | More than most peers in Dermatopathology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Scott Sanders is a dermatopathology in New City, NY. That is the designation recorded for this NPI in the federal registry.
NPI registry
Scott Sanders is listed at 301 N Main St Suite 3, New City, NY 10956. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (845) 499-2017. Contact the office directly to confirm availability and scheduling.
NPI registry
Scott Sanders's National Provider Identifier is 1780670927. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Scott Sanders attended Harvard Medical School, graduating in 1998. This comes from the CMS National Downloadable File.
CMS public data
Scott Sanders has 28 years experience. Calculated from a graduation year of 1998, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Scott Sanders performs procedures including destruction of precancer skin growth, 2-14 growths, destruction of precancer skin growth, 1 growth and destruction of skin growth, 1-14 growths; provides treatments such as test for allergy using skin patch and treatment of inflammatory skin disease using laser, less than 250.0 sq cm, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Scott Sanders. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.
A GigHz company · Founder: Pouyan Golshani, MD